Abstract:Ferroptosis is a non-apoptotic form of regulated cell death characterized by iron-dependent lipid peroxidation. It can be triggered by various mechanisms, including the glutathione peroxidase 4 (GPX4)-glutathione (GSH) axis, iron metabolism, lipid metabolism, the GTP cyclohydrolase 1 (GCH1)-tetrahydrobiopterin (BH4) pathway, and the ferroptosis suppressor protein 1 (FSP1)-coenzyme Q10 axis. The redox balance is disrupted when ferroptosis occurs in cells, which is fatal to cancer cells. Additionally, some tumor-associated genes are involved in ferroptosis. Hence, targeting ferroptosis might be an effective strategy for treating cancer. Several small-molecule compounds exhibit anti-tumor effects through ferroptosis, including sorafenib and altretamine, which induce ferroptosis by inhibiting System-Xc and GPX4 respectively, but many problems, such as poor druggability, still exist. Some studies have shown that many traditional Chinese medicine (TCM) induce ferroptosis by inhibiting GPX4, solute carrier family 7 member 11 (SLC7A11), and nuclear factor (erythroid-derived 2)-like 2 (Nrf2), or by increasing the expression of Acyl-CoA synthetase long-chain family member 4 (ACSL4), transferrin (TF), and transferrin receptor 1 (TFR1). These changes can lead to the lysosomal degradation of ferritin, accumulation of iron, lipid peroxidation and the production of reactive oxygen species (ROS), which in turn can promote anti-tumor activities or synergistic effects with chemotherapeutic drugs. In this study, we elucidated the underlying mechanisms of ferroptosis, and the anti-tumor pharmacology of TCM targeting ferroptosis including prescriptions, Chinese herbs, extracts, and natural compounds. Our findings might act as valuable reference for research on anti-tumor drugs targeting ferroptosis, especially those drugs developed from TCM.

Research Progress in Regulation of Ferroptosis by Epigallocatechin-3- Gallate in Tumor Cells

Targeting Ferroptosis in Breast Cancer

Epigallocatechin gallate modulates ferroptosis through downregulation of tsRNA-13502 in non-small cell lung cancer

Advances in ferroptosis of cancer therapy

Ferroptosis as a molecular target of epigallocatechin gallate in diseases

Ferroptosis and its emerging role in tumor

A review on the research progress of traditional Chinese medicine with anti-cancer effect targeting ferroptosis

Regulation mechanism of ferroptosis and its research progress in tumor immunotherapy

Prospects for Anti-Tumor Mechanism and Potential Clinical Application Based on Glutathione Peroxidase 4 Mediated Ferroptosis

Advancing the frontiers of colorectal cancer treatment: harnessing ferroptosis regulation

The Regulatory Mechanism and Research Progress of Ferroptosis in Gastric Cancer

Application of natural products for inducing ferroptosis in tumor cells

Self-assembled metal-phenolic nanocomplexes comprised of green tea catechin for tumor-specific ferroptosis

Ferroptosis and EMT: key targets for combating cancer progression and therapy resistance

The epigenetic regulators and metabolic changes in ferroptosis-associated cancer progression

Research progress on ferroptosis in colorectal cancer

Targeting Ferroptosis in Gastric Cancer: Strategies and Opportunities

The Mechanism of Ferroptosis and Applications in Tumor Treatment

Ferroptosis as a novel form of regulated cell death: Implications in the pathogenesis, oncometabolism and treatment of human cancer

The regulation and function of Nrf2 signaling in ferroptosis-activated cancer therapy